君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01877 君实生物

交易中 06-18 10:49:40

16.280

+0.390

+2.45%

最高16.570	最低15.740	成交量124.14万
今开15.800	昨收15.890	日振幅5.22%
总市值167.20亿	流通市值42.33亿	总股本10.27亿
成交额2,014万	换手率0.48%	流通股本2.60亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01877","market":"HK","secType":"STK","nameCN":"君实生物","latestPrice":16.28,"timestamp":1781750971639,"preClose":15.89,"halted":0,"volume":1241400,"delay":0,"changeRate":0.0245437382001259,"floatShares":260000000,"shares":1027000000,"eps":-0.87,"marketStatus":"交易中","change":0.39,"latestTime":"06-18 10:49:40","open":15.8,"high":16.57,"low":15.74,"amount":20142346,"amplitude":0.052234,"askPrice":16.28,"askSize":9200,"bidPrice":16.26,"bidSize":1800,"shortable":3,"etf":0,"ttmEps":-0.691,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1781755200000},"marketStatusCode":2,"adr":0,"listingDate":1545580800000,"exchange":"SEHK","adjPreClose":15.89,"openAndCloseTimeList":[[1781746200000,1781755200000],[1781758800000,1781769600000]],"volumeRatio":1.833274,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688180","market":"SH","secType":"STK","nameCN":"君实生物-U","latestPrice":30.18,"timestamp":1781750971000,"preClose":29.39,"halted":0,"volume":8276100,"delay":0,"premium":"-53.44"}},"requestUrl":"/m/hq/s/01877/tweets","defaultTab":"tweets","newsList":[{"id":"2644772361","title":"股市必读：6月17日君实生物现1笔大宗交易 机构净买入2050.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644772361","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644772361?lang=zh_cn&edition=full","pubTime":"2026-06-18 01:44","pubTimestamp":1781718256,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘，君实生物报收于29.39元，下跌1.31%，换手率1.16%，成交量8.88万手，成交额2.62亿元。交易信息汇总：6月17日主力资金净流出2087.46万元，散户资金净流入2674.11万元。大宗交易6月17日君实生物发生1笔大宗交易，机构净买入2050.3万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800001491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1515","BK1161","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644761786","title":"股市必读：6月16日君实生物发生1笔大宗交易 成交金额1958.88万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644761786","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644761786?lang=zh_cn&edition=full","pubTime":"2026-06-17 01:38","pubTimestamp":1781631490,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，君实生物报收于29.78元，下跌1.39%，换手率1.52%，成交量11.66万手，成交额3.45亿元。当日关注点交易信息汇总：6月16日君实生物主力资金净流出2350.54万元，散户资金净流入3057.55万元。公司公告汇总：持股5%以上股东上海檀英及其一致行动人合计持股比例由7.91%减少至6.94%，权益变动触及1%刻度。大宗交易6月16日君实生物发生1笔大宗交易，成交金额1958.88万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700000623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK1161","BK1583","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643758749","title":"君实生物（688180）披露持股5%以上股东权益变动触及1%刻度公告，6月16日股价下跌1.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643758749","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643758749?lang=zh_cn&edition=full","pubTime":"2026-06-16 17:40","pubTimestamp":1781602846,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，君实生物报收于29.78元，较前一交易日下跌1.39%，最新总市值为305.75亿元。君实生物于近日披露《关于持股5%以上股东权益变动触及1%刻度的提示性公告》。公告显示，公司持股5%以上股东上海檀英及其一致行动人LVC Fund II、LVC Renaissance Fund因基金期限与流动性资金安排，合计持股比例由7.91%减少至6.94%，权益变动触及1%刻度。本次权益变动不触及要约收购，未导致公司控股股东及实际控制人发生变化，不涉及披露权益变动报告书。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600031853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","01877","BK1583","BK0239","BK1161","688180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643498274","title":"6月15日君实生物发生1笔大宗交易 成交金额1980万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2643498274","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643498274?lang=zh_cn&edition=full","pubTime":"2026-06-15 17:52","pubTimestamp":1781517163,"startTime":"0","endTime":"0","summary":"证券之星消息，6月15日君实生物发生大宗交易，交易数据如下：大宗交易成交价格30元，相对当日收盘价折价0.66%，成交66万股，成交金额1980万元，买方营业部为中信建投证券股份有限公司总部，卖方营业部为中信证券股份有限公司上海浦东新区东方路证券营业部。近三个月该股共发生6笔大宗交易，合计成交3.96万手，折价成交6笔。截至2026年6月15日收盘，君实生物报收于30.2元，下跌1.6%，换手率1.76%，成交量13.46万手，成交额4.07亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061500023192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877","BK1515","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643217671","title":"每周股票复盘：6月8日至12日君实生物（688180）连续获机构大宗交易净买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2643217671","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643217671?lang=zh_cn&edition=full","pubTime":"2026-06-14 01:14","pubTimestamp":1781370853,"startTime":"0","endTime":"0","summary":"截至2026年6月12日收盘，君实生物报收于30.69元，较上周的30.12元上涨1.89%。本周，君实生物6月12日盘中最高价报30.89元。6月9日盘中最低价报28.1元，股价触及近一年最低点。君实生物当前最新总市值315.09亿元，在生物制品板块市值排名6/51，在两市A股市值排名663/5206。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061400000142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","688180","BK1515","BK0239","BK1583","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642250194","title":"港股异动 | 君实生物(01877)涨超5% 近日拟入股上海致域生物医药 布局ADC与多特异抗体研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2642250194","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642250194?lang=zh_cn&edition=full","pubTime":"2026-06-12 15:07","pubTimestamp":1781248026,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，君实生物涨超5%，截至发稿，涨4.67%，报17.26港元，成交额6560.03万港元。消息面上，近日，君实生物发布公告，公司拟与苏州众合、君实工程、苏州君盟、合资公司上海致域生物医药有限公司及姚盛博士订立合资协议，据此，转让方有条件同意向合资公司授予许可知识产权的一项许可，用于许可产品的研究、开发、制造、使用及商业化；向合资公司转让有形资产；及向合资公司转让IP权益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453627.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ADC","BK4581","161726","399441","01877","BK4585","BK4080","BK1161","XBI","BK1515","BK1583","VXUS","BK4231","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642254781","title":"医药板块集体回升 科伦博泰生物(06990)涨7.20%、荣昌生物(09995)涨6.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642254781","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642254781?lang=zh_cn&edition=full","pubTime":"2026-06-12 13:30","pubTimestamp":1781242214,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股医药板块集体回升，科伦博泰生物 涨7.20%，荣昌生物涨6.53%，康诺亚-B涨5.58%，复宏汉霖涨5.36%，康方生物涨5.07%，君实生物涨4.61%，药明合联涨4.06%，诺诚健华涨3.96%。英伟达同时为 Abridge 投资方，新模型基于英伟达开放模型套件 Nemotron 训练，Abridge 将采用去标识化临床数据进行定制优化，预计 2026 年晚些时候上线。东莞证券研报认为，受行业合规整顿以及消费疲软等因素影响，2025年医药生物行业整体归母净利润同比有所下滑。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983673","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688331","SG9999014674.SGD","LU0417516902.SGD","LU1969619763.USD","09969","LU2476274308.USD","LU0348825331.USD","09939","LU1720050803.USD","09926","BK0239","HK0000165453.HKD","HK0000306701.USD","LU2399975544.HKD","LU1794554557.SGD","LU2488822045.USD","LU0561508036.HKD","HK0000306685.HKD","HK0000320264.USD","LU1961090484.USD","BK1583","LU0634319403.HKD","LU2328871848.SGD","06990","LU1064130708.USD","09995","LU1064131003.USD","BK1161","LU0348784397.USD","02162","LU0540923850.HKD","01877","LU0348735423.USD","BK1587","02268","HK0000320223.HKD","LU2148510915.USD","LU0348827113.USD","LU0417516571.SGD","LU0348783233.USD","BK1515","LU0417516738.SGD","LU0348767384.USD","BK1141","159938","LU0348766576.USD","LU2476274720.SGD","02696","IE00BPRC5H50.USD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642285520","title":"君实生物与中科院微生物就四价重组登革热疫苗达成独占许可合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2642285520","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642285520?lang=zh_cn&edition=full","pubTime":"2026-06-11 17:30","pubTimestamp":1781170200,"startTime":"0","endTime":"0","summary":"上海2026年6月11日 /美通社/ -- 北京时间2026年6月11日，君实生物控股子公司君拓生物与中国科学院微生物研究所达成合作，君拓生物将被授予四价重组登革热疫苗在全球层面的相关独占许可权益。此次君实生物与中科院微生物所达成四价重组登革热疫苗全球独占许可合作，将为登革热防控带来新的希望。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4981416_ZH81416_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK0239","688180","BK1515","01877","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642442743","title":"6月10日君实生物现1936.44万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2642442743","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642442743?lang=zh_cn&edition=full","pubTime":"2026-06-10 17:43","pubTimestamp":1781084620,"startTime":"0","endTime":"0","summary":"证券之星消息，6月10日君实生物发生大宗交易，交易数据如下：大宗交易成交价格29.34元，相对当日收盘价折价0.64%，成交66万股，成交金额1936.44万元，买方营业部为中信建投证券股份有限公司总部，卖方营业部为中信证券股份有限公司上海浦东新区东方路证券营业部。近三个月该股共发生6笔大宗交易，合计成交3.04万手，折价成交3笔。截至2026年6月10日收盘，君实生物报收于29.53元，上涨0.82%，换手率1.48%，成交量11.35万手，成交额3.3亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000031526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","01877","BK1515","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641483963","title":"6月8日君实生物现1笔大宗交易 机构净买入1982.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2641483963","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641483963?lang=zh_cn&edition=full","pubTime":"2026-06-08 17:58","pubTimestamp":1780912683,"startTime":"0","endTime":"0","summary":"证券之星消息，6月8日君实生物发生大宗交易，交易数据如下：大宗交易成交价格28.73元，相对当日收盘价折价0.69%，成交69万股，成交金额1982.37万元，买方营业部为机构专用，卖方营业部为中信证券股份有限公司上海浦东新区东方路证券营业部。近三个月该股共发生4笔大宗交易，合计成交1.75万手，折价成交1笔。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800024760.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1515","01877","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144895873","title":"君实生物子公司部分项目持股结构变更获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1144895873","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144895873?lang=zh_cn&edition=full","pubTime":"2026-06-05 22:12","pubTimestamp":1780668771,"startTime":"0","endTime":"0","summary":"君实生物宣布，其部分子项目的实施主体持股结构变更方案已获通过。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1583","01877","688180","BK1161","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106400533","title":"上海君实生物 - 君研弘石拟增资1亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1106400533","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106400533?lang=zh_cn&edition=full","pubTime":"2026-06-05 22:10","pubTimestamp":1780668625,"startTime":"0","endTime":"0","summary":"上海君实生物科技股份有限公司旗下子公司君研弘石计划增加注册资本1亿元人民币。此举旨在提升其运营资本与业务发展能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","688180","BK1515","BK0239","BK1583","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641143811","title":"君实生物：公司将于2026年6月26日召开2025年年度股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2641143811","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641143811?lang=zh_cn&edition=full","pubTime":"2026-06-05 20:40","pubTimestamp":1780663200,"startTime":"0","endTime":"0","summary":"证券日报网讯6月5日，君实生物发布公告称，公司将于2026年6月26日召开2025年年度股东会。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-06-05/doc-iniakmqn8278591.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-06-05/doc-iniakmqn8278591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","BK1515","01877","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641148898","title":"君实生物：副总姚盛转任非执行董事 独董张淳届满离任 提名陈良为独董候选人","url":"https://stock-news.laohu8.com/highlight/detail?id=2641148898","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641148898?lang=zh_cn&edition=full","pubTime":"2026-06-05 20:08","pubTimestamp":1780661280,"startTime":"0","endTime":"0","summary":"6月5日，君实生物（688180/01877）发布公告，姚盛因其他工作安排，申请辞去副总经理及部分子公司职务，其辞职后将被调任为非执行董事。同时，独立非执行董事张淳因任期届满离任，其离任后不在公司继续任职，公司已提名陈良为独立非执行董事候选人。公告中提到，在姚盛离职后，其负责的工作将由执行董事、总经理兼首席执行官邹建军和执行董事、副总经理张卓兵共同承担。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606053762146079.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1583","01877","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641117627","title":"君实生物：拟以知识产权及资产作价5308.11万元对外投资关联公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2641117627","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641117627?lang=zh_cn&edition=full","pubTime":"2026-06-05 19:21","pubTimestamp":1780658477,"startTime":"0","endTime":"0","summary":"君实生物(688180.SH)公告称，公司及全资子公司拟以知识产权权益及实物资产作价5308.11万元认购上海致域生物医药有限公司新增注册资本25万元。同时，四名天使轮投资人拟以1500万美元认购合资公司新增注册资本，完成后公司预计持有合资公司14.55%股权。本次交易构成关联交易，尚需股东会审议。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500035476.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK1583","01877","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148450351","title":"君实生物5月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1148450351","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148450351?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:48","pubTimestamp":1780476485,"startTime":"0","endTime":"0","summary":"上海君实生物医药科技股份有限公司于2026年6月3日发布截至2026年5月31日的股份变动月报表。根据公告，报告期内公司股本结构保持不变。报告期末，H股已发行股份260,295,700股，A股已发行股份765,578,300股，库存股815,871股，总体数量与上月底保持一致，未发生新增、回购、注销或库藏股数量变动。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640937525","title":"破发股君实生物跌3.53% 2020年上市2募资共86亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2640937525","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640937525?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:00","pubTimestamp":1780304404,"startTime":"0","endTime":"0","summary":"中国经济网北京6月1日讯 君实生物 今日收报33.03元，跌幅3.53%。该股目前处于破发状态。　　上市首日，君实生物股价最高报220.40元，为上市以来股价最高点。　　君实生物首次公开发行股票募集资金总额为48.36亿元，扣除发行费用后，募集资金净额为44.97亿元，较原计划多17.97亿元。　　君实生物首次公开发行股票发行费用为3.39亿元，其中，保荐及承销费用3.20亿元。　　经计算，君实生物两次募集资金合计86.12亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260601/32266246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1583","BK1161","BK1515","IPOS","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640934504","title":"智通AH统计|6月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=2640934504","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640934504?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:15","pubTimestamp":1780301706,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止6月1日收盘，东北电气、浙江世宝、弘业期货分列AH溢价率前三位，溢价率分别为671.43%、372.38%、313.93%；宁德时代、兆易创新、药明康德分列AH溢价率末三位，溢价率分别为-33.22%、-19.56%、-4.81%。其中东北电气、新天绿色能源、晨鸣纸业的偏离值位居前三，分别为93.47%、53.80%、38.74%；另外，龙旗科技、胜宏科技、福莱特玻璃的偏离值位居后三，分别为-18.29%、-16.28%、-14.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448457.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02476","02238","03145","06865","01108","01033","399300","601318","IE0031814852.USD","EWH","159982","01375","01812","LU2778985437.USD","09611","02039","01057","00568","PNGAY","03986","03328","03678","BK1170","03968","00699","00042","01349","LU0831093199.SGD","HPAD.SI","00956","01276","03143","01330","00588","01877","00763","02218","PAImain","02338","03750","03347","82318","02628","LU0228367735.SGD","02318","00916","02359","IE00BZ08YS42.EUR","00300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639601948","title":"每周股票复盘：君实生物（688180）特瑞普利单抗围手术期治疗达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2639601948","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639601948?lang=zh_cn&edition=full","pubTime":"2026-05-31 01:36","pubTimestamp":1780162573,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，君实生物报收于34.24元，较上周的37.13元下跌7.78%。本周，君实生物5月25日盘中最高价报37.22元。公司公告汇总君实生物自愿披露关于特瑞普利单抗联合化疗用于II-III期可切除非小细胞肺癌患者围手术期治疗的III期临床研究达到最终分析主要研究终点的公告。公司计划递交补充申请，拟将适应症扩展至II-III期患者。该药已在国内获批13项适应症，其中12项纳入国家医保目录，并在多个国家和地区获批上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","688180","01877","BK1161","BK1583","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638854800","title":"君实生物（688180）披露特瑞普利单抗围手术期治疗非小细胞肺癌III期临床研究达主要终点，5月26日股价下跌3.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638854800","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638854800?lang=zh_cn&edition=full","pubTime":"2026-05-26 22:17","pubTimestamp":1779805035,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，君实生物报收于35.2元，较前一交易日下跌3.48%，最新总市值为361.39亿元。该股当日开盘36.05元，最高36.62元，最低34.79元，成交额达5.04亿元，换手率为1.86%。近日，上海君实生物医药科技股份有限公司发布公告称，其产品特瑞普利单抗联合化疗用于II-III期可切除非小细胞肺癌患者围手术期治疗的III期临床研究已完成最终分析，主要研究终点II-III期人群的无事件生存期、主要病理学缓解率及III期人群MPR率均达到预设优效界值。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600041158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1161","BK1515","688180","01877","BK1583"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://junshipharma.com","stockEarnings":[{"period":"1week","weight":-0.0428},{"period":"1month","weight":-0.3055},{"period":"3month","weight":-0.2698},{"period":"6month","weight":-0.3163},{"period":"1year","weight":-0.3238},{"period":"ytd","weight":-0.2554}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":-0.0531},{"period":"3month","weight":-0.0466},{"period":"6month","weight":-0.0537},{"period":"1year","weight":0.0138},{"period":"ytd","weight":-0.0514}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海君实生物医药科技股份有限公司是一家主要从事创新驱动生物制药业务的中国公司。该公司主营业务为创新药物的发现、临床研究和开发。该公司的主要产品包括特立普珠单抗注射液、依替维单抗、阿达木单抗注射液等用于治疗恶性肿瘤、自身免疫系统疾病、慢性代谢疾病、神经系统疾病和感染性疾病的药物。该公司还从事重组人源化抗PCSK9单克隆抗体注射液等药物的临床研发。该公司主要为国内外市场提供产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.098181},{"month":2,"riseRate":0.75,"avgChangeRate":0.062525},{"month":3,"riseRate":0.75,"avgChangeRate":0.059343},{"month":4,"riseRate":0.875,"avgChangeRate":0.105939},{"month":5,"riseRate":0.375,"avgChangeRate":-0.021039},{"month":6,"riseRate":0.375,"avgChangeRate":-0.04667},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.014588},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.040587},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.026161},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.004518},{"month":11,"riseRate":0.571429,"avgChangeRate":0.043753},{"month":12,"riseRate":0.571429,"avgChangeRate":0.085319}],"exchange":"SEHK","name":"君实生物","nameEN":"JUNSHI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"君实生物,01877,君实生物股票,君实生物股票老虎,君实生物股票老虎国际,君实生物行情,君实生物股票行情,君实生物股价,君实生物股市,君实生物股票价格,君实生物股票交易,君实生物股票购买,君实生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}